NEW YORK (GenomeWeb News) – Illumina’s shareholders yesterday approved an increase in the number of authorized shares of the firm’s stock to 320 million from 120 million, clearing the way for a proposed 2-for-1 stock split.
 
Illumina had announced the proposed stock split in July. Today is the date of record for the split, and Sept. 22 is the date on which additional shares will be distributed to shareholders.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.